Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LRRC78P (Leucine rich repeat containing 78, pseudogene) is a human pseudogene. Unlike protein-coding genes, pseudogenes such as LRRC78P do not produce functional proteins. Pseudogenes are often derived from gene duplication or retrotransposition events and have typically lost the capacity for protein coding through mutations, deletions, or premature stop codons. Though most pseudogenes are considered non-functional "genomic fossils," some are transcribed into non-coding RNA. These transcripts can play regulatory roles by affecting their protein-coding counterparts, serving as sources of small interfering RNAs (siRNAs) or acting as molecular decoys for microRNAs. However, there is no current evidence of any protein product, regulatory function, disease association, or therapeutic interest for LRRC78P specifically[1][3][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Leucine rich repeat containing 78, pseudogene (LRRC78P).